Clinical Trials Study
Copyright ©The Author(s) 2023.
World J Clin Cases. Feb 26, 2023; 11(6): 1299-1309
Published online Feb 26, 2023. doi: 10.12998/wjcc.v11.i6.1299
Table 2 Cephalometric analysis and comparison of changes and calculated measurement items after mandibular advancement treatment
Measurement
Pre-treatment T0
Post treatment T1
Difference T1-T0
T value
P value
ss/OLP (mm)71.42 ± 3.7672.02 ± 4.050.60 ± 0.82-0.5320.258
Pg/OLP (mm)72.55 ± 3.2575.68 ± 4.533.13 ± 0.89-1.5610.029a
Co-OLP (mm)-8.57 ± 0.65-9.60 ± 0.45-1.03 ± 0.79-1.3490.000c
Pg/OLP + Co/OLP (mm)82.01 ± 1.5786.25 ± 2.054.14 ± 2.18-1.6870.000c
Co-Go (mm)50.03 ± 4.1554.12 ± 3.654.09 ± 1.58-3.0370.018a
Go-Pg (mm)76.18 ± 5.4380.43 ± 3.904.25 ± 2.87-4.5810.001b
Co-Pg (mm)108.58 ± 7.08113.60 ± 6.585.02 ± 1.83-3.8030.038a
SNA (°)80.95 ± 1.9080.67 ± 1.54-0.28 ± 0.041.9150.166
SNB (°)74.89 ± 1.7876.85 ± 1.651.96 ± 2.563.2180.000c
ANB (°)6.11 ± 1.064.08 ± 1.34-2.03 ± 1.3218.3700.000c
Wits (mm)6.41 ± 2.453.51 ± 1.18-2.90 ± 1.727.1380.000c
SN-MP (°)31.20 ± 3.6232.85 ± 3.511.65 ± 1.37-1.4780.043a
S-Go/N-Me64.12 ± 2.6862.08 ± 3.09-2.04 ± 1.681.3860.035a
ANS-Me/N-Me54.40 ± 1.8955.85 ± 2.181.45 ± 1.37-2.0870.045a
is/OLP77.98 ± 6.0776.65 ± 5.71-1.33 ± 3.081.6570.353
ii/OLP71.11 ± 5.0474.09 ± 4.762.98 ± 1.08-1.7090.071
ms/OLP46.86 ± 5.3445.67 ± 4.87-1.19 ± 0.391.6870.205
mi/OLP45.30 ± 3.2847.80 ± 5.182.50 ± 1.04-1.5600.082
U1-NA28.89 ± 7.5125.45 ± 5.40-3.44 ± 6.89-7.7600.010a
U1-SN108.04 ± 3.01103.98 ± 4.78-4.06 ± 4.884.6730.000c
L1-MP95.20 ± 2.9396.43 ± 2.861.23 ± 0.40-0.3180.000c
L1-NB22.78 ± 4.0825.40 ± 3.322.62 ± 1.63-3.3410.030a
is/OLP-ii/OLP6.87 ± 1.512.56 ± 0.76-4.31 ± 1.4316.300.000c
ms/OLP-mi/OLP2.13 ± 1.20-1.74 ± 1.31-3.87 ± 0.7810.610.000c
is/OLP-ss/OLP7.04 ± 1.076.48 ± 2.09-0.61 ± 1.714.250.089
ii/OLP-pg/OLP-1.12 ± 1.650.05 ± 1.701.17 ± 0.831.750.005b
ms/OLP-ss/OLP-23.18 ± 2.69-24.34 ± 1.98-1.16 ± 1.78-15.680.000c
mi/OLP-pg/OLP-26.98 ± 2.45-26.80 ± 2.780.18 ± 1.573.050.185